Saladax, Bristol-Myers Squibb Expand Relationship | GenomeWeb

NEW YORK (GenomeWeb News) – Saladax today said it has expanded its relationship with Bristol-Myers Squibb and entered into a Master Early Development Collaboration Agreement.

As a result of the expansion, the companies may collaborate on multiple feasibility studies and companion diagnostic development projects, they said, adding they have already started a companion diagnostic project in an undisclosed field.

Financial terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.